OncoveryCare's survivorship-trained clinicians will treat the chronic and late-effects of cancer treatment to help bring comprehensive care to New York Cancer & Blood Specialists' cancer survivor population.

RIDGE, NY / ACCESS Newswire / September 24, 2025 / New York Cancer & Blood Specialists (NYCBS), one of the nation's leading community oncology practices, today announced a partnership with OncoveryCare to provide personalized, ongoing care to the NYCBS survivor population. Beginning today, OncoveryCare will work alongside NYCBS oncologists to treat the chronic and late effects of cancer treatment and provide comprehensive cancer follow-up care for NYCBS patients.

As cancer diagnoses increase and mortality rates fall with improvements in treatment, survivorship has become one of cancer care's most urgent priorities. By 2040, the number of cancer survivors in the United States is expected to reach 26 million - up from 18 million in 2022. At the same time, cancer is increasingly diagnosed at younger ages, leaving survivors to manage its effects for decades. Survivorship care addresses the full spectrum of needs beyond treatment - including managing treatment toxicities, chronic co-morbidities, and mental health. Integrating survivorship into oncology ensures patients receive continuous, comprehensive care.

Through this collaboration, OncoveryCare will deliver comprehensive survivorship care, including integrated medical and behavioral healthcare, to help cancer survivors fully engage in life after cancer. OncoveryCare's clinical team comprises survivorship-trained Advanced Practice Providers and Licensed Clinical Social Workers with extensive experience in medical oncology, who treat survivorship-related conditions such as fatigue, joint pain, sexual dysfunction, insomnia, anxiety, and more. OncoveryCare clinicians are integrated as part of the broader oncology team - working in close collaboration with the patient's existing care team.

Dr. Jeff Vacirca, CEO of NYCBS and Co-founder of OneOncology, said "Cancer survivorship is one of the most important frontiers in oncology. Our partnership with OncoveryCare ensures that our patients don't just survive cancer, but truly thrive in life after treatment. Together, we are setting a new standard for comprehensive survivorship care that addresses every aspect of a patient's well-being."

"Cancer doesn't end when treatment does, and neither should care," said Dr. MaryAnn Fragola, Chief of Wellness Services at NYCBS. "Through our partnership with OncoveryCare, we are strengthening our commitment to whole-person, patient-centered care by addressing the long-term medical, emotional, and on-going needs of survivors and their loved ones."

Hil Moss, Co-Founder and CEO of OncoveryCare, said "New York Cancer & Blood Specialists is an innovative leader in oncology, and we're thrilled to launch a partnership that will transform care for survivors in New York." Dr. Justin Grischkan, Co-Founder and Chief Medical Officer at OncoveryCare, added, "We are inspired by NYCBS's commitment to providing comprehensive survivorship care to their patients."

About New York Cancer & Blood Specialists

New York Cancer & Blood Specialists is a leading oncology practice dedicated to providing world class, patient-centered, and affordable care to individuals with cancer and blood disorders throughout New York State. With locations across Long Island, New York City, and Upstate New York, our mission is to bring world-class cancer care close to home, where patients can heal with the support of family and community.

About OncoveryCare

OncoveryCare delivers comprehensive, whole-person care to cancer survivors. As the population of survivors grows rapidly alongside advances in medicine, OncoveryCare provides the personalized, longitudinal care that cancer survivors need to lead happier, healthier lives. Founded by a breast cancer survivor and a physician, OncoveryCare deploys a survivorship-trained clinical team to treat the chronic and late-effects of each survivor's cancer treatment and equip survivors with the tools they need to manage their survivorship journey.

OncoveryCare is backed by leading investors and oncology stakeholders, including .406 Ventures, Tennessee Oncology's McKay Institute, F-Prime, and Oncology Ventures. Learn more at www.oncoverycare.com, and follow us on LinkedIn and Instagram @oncoverycare.

Media Contact
Chloe Baldwin
Senior Manager, Community & Marketing
chloe@oncoverycare.com

SOURCE: OncoveryCare